Page 2 - Contribuciones
P. 2

J. F. Villa-Manríquez, J. Castro-Ramos, F. Gutiérrez-Delgado, M. A. Lopéz-Pacheco, A. E. Villanueva-Luna3.
       Raman spectroscopy and PCA-SVM as a non-invasive diagnostic tool to identify and classify qualitatively glycated
       hemoglobin levels in vivo.
       J. Biophotonics 1–6 (2016) / DOI 10.1002/jbio.201600169

          M. Schuler, J. C.-H., Yang, K. Park et al. Afatinib beyond
         progression in patients with non-small-cell lung cancer
         following chemotherapy, erlotinib/gefitinib and afatinib:
         phase III randomized LUX-Lung 5 trial. Ann Oncol. 2016;
         27(3): 417–423.
                                                            F. Gutierrez Delgado. Early Cancer Detection:
                                                            Current status and emerging strategies.
                                                            Practical Oncology 2016; 17(1): 11-14


         Wilke H, Muro K, Van Cutsem E, et al, for the RAINBOW Study Group. Ramucirumab plus paclitaxel
         versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal
         junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol 2014; 15
         (11): 1224–1235

   1   2   3   4   5   6   7